References and Notes
1a
Field SC.
Tetrahedron
1999,
55:
12237
1b
Heaney F.
In Comprehensive Organic Functional Group Transformations
Vol. 4:
Katritzky AR.
Meth-Kohn O.
Rees CW.
Elsevier Science;
Oxford UK:
1995.
Chap. 4.
p.10
2a
Atherton FR.
Hassall CH.
Lambert RW.
J. Med. Chem.
1986,
29:
29 ; and references cited therein
2b
Kafarski P.
Lejcazk B.
Phosphorus, Sulfur Silicon Relat. Elem.
1991,
63:
193
2c
Bird J.
De Mello RC.
Harper HP.
Hunter DJ.
Karran EH.
Markwell ER.
Miles-Williams AJ.
Rahman SS.
Ward RW.
J. Med. Chem.
1994,
37:
158
2d
McLeod DA.
Brinkworth RI.
Ashley JA.
Janda KD.
Wirsching P.
Bioorg. Med. Chem. Lett.
1991,
1:
653
2e
Hirschmann R.
Smith AB.
Taylor CM.
Benkovic PA.
Taylor SD.
Yager KM.
Sprengeler PA.
Benkovic SJ.
Science (Washington, D.C.)
1994,
265:
234
2f
Grembecka J.
Mucha A.
Cierpicki T.
Kafarski P.
J. Med. Chem.
2003,
46:
2641
3a
Filler R.
Kobayashi Y.
Yagupolski LM. In
Organofluorine Compounds in Medicinal Chemistry and Biomedicinal Applications
Elsevier Science;
Amsterdam:
1993.
3b
Ojima I.
McCarthy J.
Welch JT.
Biomedicinal Frontiers of Fluorine Chemistry, ACS Symposium Series 639
ACS;
Washington, D.C.:
1996.
4
Banks RE.
Tatlow JC.
Smart BE. In
Organofluorine Chemistry: Principles and Commercial Applications
Plenum Press;
New York:
1994.
5a
Osipov SN.
Kolomiets AF.
Fokin AV.
Russ. Chem. Rev.
1992,
61:
798 ; and references cited therein
5b
Osipov SN.
Golubev AG.
Sewald N.
Kolomiets AF.
Fokin AV.
Burger K.
Synlett
1995,
1269
5c
Osipov SN.
Golubev AS.
Sewald N.
Michel T.
Kolomiets AF.
Fokin AV.
Burger K.
J. Org. Chem.
1996,
61:
7521
5d
Osipov SN.
Artyushin OI.
Kolomiets AF.
Mendeleev Commun.
2000,
5:
192
5e
Kobel’kova NM.
Osipov SN.
Kolomiets AF.
Russ. Chem. Bull.
2002,
7:
1298
6a
Shi G.
Xu Y.
Chem. Commun.
1989,
607
6b
Shi G.
Xu Y.
J. Org. Chem.
1990,
55:
3383
6c
Shi G.
Xu Y.
Xu M.
Tetrahedron
1991,
47:
1629
6d
Shi G.
Xu Y.
Xu M.
J. Fluorine Chem.
1991,
52:
149
6e
Shi G.
Cao Z.
Cai W.
Tetrahedron
1995,
51:
5011
6f
Paulini K.
Reissig H.-U.
J. Prakt. Chem./Chem.-Ztg.
1995,
337:
55
6g
Osipov SN.
Sewald N.
Burger K.
Kolomiets AF.
Fokin AV.
Tetrahedron Lett.
1996,
37:
615
6h
Jiang B.
Zhang Z.
Luo Z.
Org. Lett.
2002,
4:
2453
6i
Mueller P.
Grass S.
Shahi SP.
Bernardinelli G.
Tetrahedron
2004,
60:
4755
6j
Vorob’eva DV.
Titanyuk ID.
Beletskaya IP.
Osipov SN.
Mendeleev Commun.
2005,
6:
222
6k
Zhu S.
Xing C.
Zhu S.
Tetrahedron
2006,
62:
829
7a
Sinitsa AD.
Onisko PP.
Kim TV.
Kiseleva EI.
Pirozhenko VV.
J. Gen. Chem. USSR
1986,
52:
2372
7b
Flynn AG.
Beight DW.
Bohme EHW.
Metcalf BW.
Tetrahedron Lett.
1985,
26:
285
7c
Vaubaillon D.
Giraud V.
Rabiller C.
Gruss U.
Haas A.
Haegele G.
Phosphorus, Sulfur Silicon Relat. Elem.
1997,
126:
177
8a
Ingrassia L.
Mulliez M.
Synthesis
1999,
1731
8b
De Medina P.
Ingrassia LS.
Mulliez ME.
J. Org. Chem.
2003,
68:
8424
9a
Yates P.
J. Am. Chem. Soc.
1952,
74:
5376
9b
Ye T.
McKervey A.
Chem. Rev.
1994,
94:
1091 ; and references cited therein
9c
Aller E.
Buck RT.
Drysdale MJ.
Ferris L.
Haigh D.
Moody CJ.
J. Chem. Soc., Perkin Trans. 1
1996,
2879
9d
Ferris L.
Haigh D.
Moody CJ.
J. Chem. Soc., Perkin Trans. 1
1996,
2885
9e
Moody CJ.
Ferris L.
Haigh D.
Swann E.
Chem. Commun.
1997,
2391
10
Diethyl (1-Diazo-2,2,2-trifluoroethyl)phosphonate (
4) The reaction was conducted in a 500 mL flask equipped with a condenser, a funnel, and magnetic stirrer. i-PrONO (9.5 g, 0.106 mol) was added to a vigorously stirred solution of aminophosphonate (19.6 g, 0.083 mol) in CHCl3 (300 mL). After the addition of approximately 1.0 g of i-PrONO an exothermic reaction began; the rest of the nitrite was added dropwise providing a mild refluxing reaction mixture for 20 min. After stirring for an additional 40 min (the temperature was reduced to r.t.) the solvent was removed under reduced pressure and the residue was distilled in vacuo to afford 13.7 g (67%) of diazo compound 4 as light yellow liquid. Bp 47-50 °C (1 Torr). IR (KBr): 2160, 1150 cm-1. 1H NMR (CDCl3): δ = 1.40 (t, 6 H, J = 7.1 Hz), 4.15-4.30 (m, 4 H). 13C NMR (CDCl3): δ = 15.9, 63.6, 118.6 (m), 124.1 (dq, J
C-F = 271.0 Hz, J
C-P = 12.1 Hz). 31P NMR (CDCl3): δ = 9.23. 19F NMR (CDCl3): δ = 23.0.
11
OH- and NH-Insertion; General Procedure A solution of diazo compound 4 (1.1 mmol) in anhydrous benzene (3 mL) was added to a solution of the hydroxy or amino compound (1.0 mmol) and dirhodium tetraacetate (2 mol%) in benzene (10 mL). The reaction mixture was stirred under reflux for 4 h. After evaporation of the solvent under reduced pressure the crude product was purified by column chromatography on silica gel (EtOAc-hexanes).
Diethyl (2,2,2-Trifluoro-1-methoxyethyl)phosphonate (
5a) Yield: 88%; oil. 1H NMR (CDCl3): δ = 1.38 (t, 6 H, J = 7.0 Hz), 3.65 (s, 3 H), 3.78-3.9 (m, 1 H), 4.20-4.30 (m, 4 H). 31P NMR (CDCl3): δ = 11.8 (app. q, J = 8.9 Hz). 19F NMR (CDCl3): δ = 6.7 (app. t, J = 8.5 Hz). Anal. Calcd for C7H14F3O4P: C, 33.61; H, 5.64. Found: C, 33.75; H, 5.75.
1-(Diethoxyphosphoryl)-2,2,2-trifluoroethyl N
-(
tert
-Butoxycarbonyl)
-1-phenylalaninate (
5f) Yield: 62%; oil; dr 1:1. 1H NMR (CDCl3): δ = 1.35-1.45 (m, 6 H), 1.45 (s, 9 H), 3.10 (ddd, 1 H, J = 4.1, 6.4, 14.0 Hz), 3.28 (app. dt, 1 H, J = 5.5, 14.0 Hz), 4.20-4.37 (m, 4 H), 4.78 (m, 1 H), 4.98 (m, 1 H), 5.68-5.83 (m, 1 H), 7.20-7.30 (m, 2 H), 7.30-7.41 (m, 3 H). 31P NMR (CDCl3): δ = 8.7 (app. q, J = 7.4 Hz), 9.3 (app. q, J = 7.4 Hz). 19F NMR (CDCl3): δ = 7.63 (app. t, J = 7.3 Hz), 7.84 (app. t, J = 7.3 Hz). Anal. Calcd for C20H29F3NO7P: C, 49.70; H, 6.00; N 2.90. Found: C, 49.51; H, 6.21; N 2.75.
Diethyl (2,2,2-Trifluoro-1-phenoxyethyl)phosphonate (
5g) Yield: 78%; oil. 1H NMR (CDCl3): δ = 1.40 (t, 6 H, J = 7.1 Hz), 4.20-4.40 (m, 4 H), 4.88-5.00 (m, 1 H), 7.05-7.15 (m, 3 H), 7.40-7.50 (m, 2 H). 31P NMR (CDCl3): δ = 10.6 (app. q, J = 8.9 Hz). 19F NMR (CDCl3): δ = 7.10 (app. t, J = 8.2 Hz). Anal. Calcd for C12H16F3O4P: C, 46.16; H, 5.17. Found: C, 46.27; H, 5.21.
Diethyl {1-[(
tert
-Butoxycarbonyl)amino]-2,2,2-trifluoroethy}phosphonate (
6a) Yield: 59%; white crystals; mp 81.5-82.5 °C. 1H NMR (CDCl3): δ = 1.41 (t, 6 H, J = 8.1 Hz), 1.52 (s, 9 H), 4.20-4.30 (m, 4 H), 4.65-4.80 (m, 1 H), 5.20 (m, 1 H). 31P NMR (CDCl3): δ = 13.6 (app. q, J = 6 Hz). 19F NMR (CDCl3): δ = 8.05 (app. t, J = 7.5 Hz). Anal. Calcd for C11H21F3NO5P: C, 39.41; H, 6.31; N, 4.18. Found: C, 39.47; H, 6.31; N, 4.15.
Diethyl {1-[(Phenylsulfonyl)amino]-2,2,2-trifluoroethyl}phosphonate (
6c) Yield: 64%; white solid; mp 115-117 °C. 1H NMR (CDCl3): δ = 1.33 (t, 3 H, J = 7.1 Hz), 1.39 (t, 3 H, J = 7.1 Hz), 4.10-4.30 (m, 4 H), 4.35-4.57 (m, 1 H), 7.05-7.15 (m, 1 H), 7.30-7.65 (m, 3 H), 7.92-7.97 (m, 2 H). 31P NMR (CDCl3): δ = 12.3 (app. q, J = 7.4 Hz). 19F NMR (CDCl3): δ = 8.03 (app. t, J = 8.0 Hz). Anal. Calcd for C12H17F3NO5PS: C, 38.40; H, 4.57; N, 3.73. Found: C, 38.21; H, 4.44; N, 3.67.
Diethyl {1-[(Pentafluorophenyl)amino]-2,2,2-trifluoroethyl}phosphonate (
6d) Yield: 63%; white solid; mp 55-56 °C. 1H NMR (CDCl3): δ = 1.40 (dt, 6 H, J = 0.7, 7.1 Hz), 4.20-4.38 (m, 4 H), 4.38-4.50 (m, 1 H).
31P NMR (CDCl3): δ = 13.2 (app. q, J = 7.4 Hz). 19F NMR (CDCl3): δ = 8.06 (app. t, J = 7.8 Hz, 3 F), -78.0 (d, J = 21.8 Hz, 2 F), -85.2 (dt, J = 5.8, 21.8 Hz, 2 F), -88.9 (t, J = 21.8 Hz, 1 F). Anal. Calcd for C12H12F8NO3P: C, 35.93; H, 3.01; N, 3.49. Found: C, 36.25; H, 3.22; N, 3.47.